Local sapphire crystal maker Tera Xtal Technology Corp (鑫晶鑽) yesterday said it has filed patent infringement lawsuits in Taiwan against Apple Inc to safeguard its interests.
Apple has illegally used Tera Xtal’s patented technology to incorporate sapphire into camera lenses used in its iPhone series, company spokesperson Peggy Hsu (許雅玲) said by telephone.
The company also sued local handset retailer Senao International Co (神腦國際) and Vibo Telecom Inc (威寶電信) because they sell iPhones domestically, she said.
“Tera Xtal wants to protect its intellectual property rights and safeguard its investors’ interests. Tera has invested heavily on the sapphire technology,” Hsu said.
“Targeting the company with the biggest sales volume is just our first step,” she said, implying that the company may wage more legal battles against global brands such as Samsung Electronics Co and LG Electronics Co.
In the lawsuits filed with the Intellectual Property Court in New Taipei City, Tera Xtal demands that the named companies stop making, selling and importing products containing the “problematic components,” according to the company’s filing with the Taiwan Stock Exchange yesterday.
Tera Xtal also seeks patent infringement damages of NT$300 million (US$9.88 million), according to the filing.
Tera Xtal will not rule out filing infringement lawsuits overseas against Apple, Hsu said.
As legal wrangling has become a tool to form technology partnerships and to initiate supply contracts, Hsu said the company hopes “to apply this innovative [sapphire substrate] technology to more mobile devices by licensing patents or supplying products.”
In a separate filing, Tera Xtal said it has received a US court ruling that its sapphire crystal equipment supplier, GT Advanced Technologies, has to return US$24.29 million Tera Xtal paid for a machine it ordered, because the machine is flawed.
GT Advanced Technologies filed for bankruptcy protection in a US court in Manchester, New Hampshire, on Monday.
“We believe we can recover that payment,” Hsu said.
GT Advanced Technologies has paid back US$7 million and is to pay the remaining US$17.29 million, she said.
This time was supposed to be different. The memorychip sector, famous for its boom-and-bust cycles, had changed its ways. A combination of more disciplined management and new markets for its products — including 5G technology and cloud services — would ensure that companies delivered more predictable earnings. Yet, less than a year after memory companies made such pronouncements, the US$160 billion industry is suffering one of its worst routs ever. There is a glut of the chips sitting in warehouses, customers are cutting orders and product prices have plunged. “The chip industry thought that suppliers were going to have better control,” said
Enimmune Corp (安特羅生技) has obtained marketing approval from the Food and Drug Administration (FDA) for its EnVAX-A71 vaccine for enterovirus 71 (EV-71), becoming the nation’s first enterovirus vaccine completely made in Taiwan, it said yesterday. After spending 13 years and NT$1.5 billion (US$49.77 million) on the research and development of the vaccine, Enimmune plans to start manufacturing and marketing it by the end of March, the company said in a statement, without disclosing customer order figures. “It is possible that the vaccine would not be included in a national vaccination program initially, and consumers would need to pay for it themselves,” parent
Vaccine skeptics blocking transfusions for life-saving surgeries, Facebook groups inciting violence against doctors and a global search for unvaccinated donors — COVID-19 misinformation has bred a so-called “pure blood” movement. The movement spins anti-vaccine narratives focused on unfounded claims that receiving blood from people inoculated against COVID-19 “contaminates” the body. Some have advocated for blood banks that draw from “pure” unvaccinated people, while medics in North America say they have fielded requests from people demanding transfusions from donors who have not received a vaccine. In closed social media groups, vaccine skeptics — who brand themselves as “pure bloods” — promote violence against doctors
Asteroid mining start-up AstroForge Inc is planning to launch its first two missions to space this year as it seeks to extract and refine metals from deep space. The first launch, scheduled for April, is to test AstroForge’s technique for refining platinum from a sample of asteroid-like material. The second, planned for October, would scout for an asteroid near Earth to mine. The missions are part of AstroForge’s goal of refining platinum-group metals from asteroids, with the aim of bringing down the cost of mining these metals. It also hopes to reduce the massive amount of carbon emissions that stem from mining
RSS